List view / Grid view

Sanofi Pasteur



Sanofi sends half a million dengue vaccines to high risk Brazilians

15 August 2016 | By Sanofi

Results of the study affirm the vaccine's consistent efficacy in reducing dengue in two-thirds of the study participants, aged 9 and older. It also documents the ability of the vaccine to prevent 8 out of 10 hospitalisations and up to 93% of severe dengue cases in this age group during…


Zika Virus: a public emergency of international concern

4 February 2016 | By Victoria White, European Pharmaceutical Review

The Zika virus has taken hold in South America. Its possible link to microcephaly in newborn babies and neurological conditions has led the World Health Organization to declare a Public Health Emergency of International Concern. Here we discuss the virus, countermeasures and the race for a vaccine.